ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1233

Effect of Insoles On the Rheumatoid Foot

Emilia Moreira1, Anamaria Jones2, Hilda A. Oliveira3, Fabio Jennings1, Artur R.C. Fernandes4 and Jamil Natour5, 1Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 2Unifesp-EPM, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 3Rheumatology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 4Radiology Division, Universidade Federal de São Paulo, Sao Paulo, Brazil, 5Rheumatology Division, Universidade Federal de São Paulo, São Paulo, Brazil

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: foot disorders, functional status, pain and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects II: Clinical Features & Comorbidity/Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) is a systemic inflammatory disease characterized by peripheral polyarthritis, which may cause joint destruction and deformities, resulting in reduced function and disability. The joint involvement of the foot occurs in 85-100% of the patients with RA. The use of insoles has been a routine in the treatment of rheumatoid feet, despite the weak evidence of its use in randomized controlled trials. The aim of the present study were to evaluate the effectiveness of the use of insoles for foot pain, function, gait, foot load distribution, quality of life and patient satisfaction regarding the use of the insoles in patients with RA.

Methods: Eligible patients included women classified as RA according to the ACR criteria, aged 18-65 years old with pain in feet between 3 and 8 on a 10-cm pain scale (VAS) for walking; functional classes I, II, and III. Of the 208 patients evaluated, 80 met the eligibility criteria and were randomized into experimental (EG) or control groups (CG). The EG group made use of EVA insoles with medial arch and retrocapital support, and CG group employed flat insoles during the study. Pacients were evaluated for pain (VAS) when walking and at rest, function (HAQ), function of the feet (FFI), quality of life (SF-36), 6-minute walk test, satisfaction with the treatment (Likert scale) and dynamics baropodometry (Pro FootWalk, AMcube ®, Gargas, France) at baseline, 45 days (T45), 90 days (T90) and 180 days after randomization by a blinded evaluator.

Results: Thirty-nine and 41 patients were randomly divided into EG and CG groups, respectively. The groups were homogeneous at baseline regarding clinical and demographic characteristics. In the comparison between the groups over time, we found better results for the EG with a statistical difference for pain during walking and at rest on the right and left foot (p <0.001), stride length (p = 0.001), and satisfaction with the treatment (p = 0.039). For other variables, we found no statistically significant difference between groups.

Conclusion : The use of insoles with medial arch and retrocapital support is effective in reducing pain during walking and at rest on both feet, increasing stride length and satisfaction with the use of insoles.


Disclosure:

E. Moreira,
None;

A. Jones,
None;

H. A. Oliveira,
None;

F. Jennings,
None;

A. R. C. Fernandes,
None;

J. Natour,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-insoles-on-the-rheumatoid-foot/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology